Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring

Fang Cheng,1,2,* Fan Wang,3,* Zheng Cui,2 Qiang Li,2 Xin Liu,1 Weiming Li4 1Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, Hubei, People’s Republic of China; 2Department of Pharmacy, Union Ho...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Cheng F, Wang F, Cui Z, Li Q, Liu X, Li W
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2026-06-01
Serie:	Drug Design, Development and Therapy
Soggetti:	Chromic myeloid leukemia flumatinib therapeutic drug monitoring exposure-efficacy exposure-toxicity
Accesso online:	https://www.dovepress.com/optimizing-flumatinib-therapy-in-chinese-chronic-phase-chronic-myeloid-peer-reviewed-fulltext-article-DDDT
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!